Publication date: Jul 23, 2025
“Meurant said given the scarcity of high-end diagnostic capacity, the RT-LAMP is “a valid and acceptable solution” that offers reliable results. “During COVID, the continent was left without testing capabilities as manufacturers focused their sales in higher income settings,” Meurant told SciDev. Net. “The recent withdrawal of funding from the US government to many organisations such as WHO and USAID reinforces the need for more self-directed and sustainable solutions for African countries. “The team is now expanding the use of RT-LAMP to other priority diseases in Africa, including arboviruses such as dengue and Zika. “We did not limit our effort to clinical accuracy studies,” he added. “Its utility in this setting can only increase,” she added.
| Concepts | Keywords |
|---|---|
| Affordable | Africa |
| Biotechnology | Cent |
| China | Cost |
| Pandemic | Covid |
| Trieste | Diagnostic |
| Lamp | |
| Low | |
| Marcello | |
| Resource | |
| Rt | |
| Sensitivity | |
| Settings | |
| Specificity | |
| Team | |
| Test |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Pentaerythritol tetranitrate |
| disease | MESH | infectious diseases |
| disease | IDO | process |
| disease | IDO | country |
| drug | DRUGBANK | Gold |
| disease | MESH | Dengue |
| drug | DRUGBANK | Tropicamide |
| disease | MESH | COVID-19 |
| disease | IDO | reagent |